This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Santosh Nandan: Innovator in Mycobacterial Treatment
Introduction
Santosh Nandan is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of medical science, particularly in the treatment of mycobacterial diseases. His innovative approach has led to the development of a unique patent that addresses critical health challenges.
Latest Patents
Santosh Nandan holds a patent for "Mycobacterial inhibitors." This invention provides the use of certain succinimide compounds in the treatment of mycobacterial diseases. His work in this area is crucial for advancing therapeutic options for patients suffering from these conditions. He has 1 patent to his name.
Career Highlights
Currently, Santosh Nandan is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Some of his notable coworkers include Meenakshi Balganesh and Kantharaj Ethirajulu. Their collaboration fosters a dynamic environment for innovation and enhances the potential for impactful discoveries in the medical field.
Conclusion
Santosh Nandan's work exemplifies the spirit of innovation in addressing complex health issues. His contributions to mycobacterial treatment are paving the way for future advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
